Advertisement
Sigma-Aldrich
Sigma-Aldrich

The Scientist

» clinical trials

Most Recent

image: Robo-Eye to Enter US Market

Robo-Eye to Enter US Market

By | February 11, 2013

A retinal prosthesis, already available in Europe, can restore partial sight to people with a genetic disorder that causes blindness.

2 Comments

image: New TB Vaccine Fails Trial

New TB Vaccine Fails Trial

By | February 4, 2013

One of the most advanced tuberculosis vaccines has failed to protect infants from getting the disease in a clinical trial, but it may be effective in adults.

1 Comment

image: Dung Defeats Drugs

Dung Defeats Drugs

By | January 18, 2013

Fecal transplants outcompeted traditional antibiotics at curing a deadly intestinal infection.

0 Comments

image: Spinning Clinical Trials

Spinning Clinical Trials

By | January 16, 2013

Results of breast cancer drug trials are regularly spun to conceal bias and make the drugs seem more effective or less toxic than they really are.

0 Comments

image: Researchers Risk Insider Trading

Researchers Risk Insider Trading

By | January 14, 2013

Academics get paid handsome fees to consult with the financial industry, but run the risk of revealing confidential information that leads to illicit gains.

0 Comments

image: Failing Alzheimer’s Test?

Failing Alzheimer’s Test?

By | December 19, 2012

Two new studies claim that a shoddy test may have caused Alzheimer’s drugs to fail in clinical trials.

0 Comments

image: Top Science Scandals of 2012

Top Science Scandals of 2012

By | December 17, 2012

This year’s roundup of bad behavior in the life sciences and new initiatives to prevent misconduct

20 Comments

image: Chelation Therapy Under Scrutiny

Chelation Therapy Under Scrutiny

By | November 15, 2012

A clinical trial suggesting the heart benefits of the controversial treatment draws criticism from the scientific community.

6 Comments

image: BioTime Seeks Geron Stem Cell Assets

BioTime Seeks Geron Stem Cell Assets

By | November 13, 2012

Two former Geron CEOs make a bid for the company’s defunct human embryonic stem cell business.

1 Comment

image: Setback for Malaria Vaccine

Setback for Malaria Vaccine

By | November 9, 2012

The malaria vaccine under development by GSK and the PATH initiative only protects about one in three babies, though some researchers say those odds are better than nothing.

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Mettler Toledo
Mettler Toledo
Advertisement
Life Technologies